Ikarian Capital’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 148 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 165 |
|
|
2024
Q4 | – | Sell |
-221,437
| Closed | -$11.2M | – | 159 |
|
|
2024
Q3 | $11.2M | Sell |
221,437
-224,014
| -50% | -$11.3M | 1.56% | 7 |
|
|
2024
Q2 | $18.2M | Sell |
445,451
-119,960
| -21% | -$4.89M | 3.17% | 4 |
|
|
2024
Q1 | $24.2M | Sell |
565,411
-24,832
| -4% | -$1.06M | 2.65% | 3 |
|
|
2023
Q4 | $23.8M | Buy |
590,243
+53,523
| +10% | +$2.15M | 2.22% | 3 |
|
|
2023
Q3 | $15.8M | Buy |
+536,720
| New | +$15.8M | 1.91% | 3 |
|
|
2022
Q2 | – | Sell |
-8,564
| Closed | -$29K | – | 155 |
|
|
2022
Q1 | $29K | Buy |
8,564
+451
| +6% | +$1.53K | ﹤0.01% | 148 |
|
|
2021
Q4 | $50K | Hold |
8,113
| – | – | 0.01% | 138 |
|
|
2021
Q3 | $112K | Sell |
8,113
-51
| -0.6% | -$704 | 0.01% | 141 |
|
|
2021
Q2 | $140K | Hold |
8,164
| – | – | 0.01% | 152 |
|
|
2021
Q1 | $155K | Hold |
8,164
| – | – | 0.01% | 165 |
|
|
2020
Q4 | $236K | Buy |
+8,164
| New | +$236K | 0.01% | 119 |
|
|
2020
Q3 | – | Sell |
-22,453
| Closed | -$748K | – | 145 |
|
|
2020
Q2 | $748K | Buy |
+22,453
| New | +$748K | 0.06% | 53 |
|